OpenAlex
PricingAboutJobs
Log inGet started
Work

Targeting RAS -mutant Cancers: Is ERK the Key?

HTML

Year: 2015
Type: review
Source: Trends in cancer
DOI: 10.1016/j.trecan.2015.10.001
Authors: Meagan B. Ryan, Channing J. Der, Andrea Wang-Gillam, Adrienne D. Cox
Institutions: University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Washington University in St. Louis, Alvin J. Siteman Cancer Center
Language: English

Topic: Protein Kinase Regulation and GTPase Signaling
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: RAS mutations, oncogenic Ras, ERK inhibitor, MAPK signaling, RAS-driven cancers
SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute, National Center for Advancing Translational Sciences
Awards: Washington University Institute of Clinical and Translational Sciences, Mechanisms of PAK1 activation, signaling and tumor resistance, Defining the role of ERK1 and ERK2 in Pancreatic Cancer, Biological Activity of Ras Oncogenes, ERK inhibitor resistance and ERK isoform-dependent growth in pancreatic cancer, Washington University Institute of Clinical and Translational Sciences, Identification of synthetic lethal interactors in pancreatic cancer, Cancer Cell Biology Training Program
OpenAlex ID: W2178192018
FWCI: 1.455
Cites: 103
Cited by: 140
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security